ASX 200 midday update: NAB disappoints, Qantas announces acquisition

The ASX 200 is having a better day on Thursday…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) has followed the lead of US markets and is pushing higher. The benchmark index is currently up 0.65% to 7,352.5 points.

Here's what is happening on the ASX 200 today:

A man analyses stockmarket graph on his computer.

Image source: Getty Images

NAB half-year results disappoint

The National Australia Bank Ltd (ASX: NAB) share price is in the red today after the bank's half-year results disappointed. For the six months ended 31 March, NAB reported a 4.6% increase in revenue to $9,071 million and a 4.1% lift in cash earnings to $3,480 million. However, this was short of the market's expectations. Furthermore, NAB has abandoned its cost base targets and now expects its operating expenses to increase by 2% to 3% in FY 2022.

Janus Henderson shares crash

Investors have been selling down the Janus Henderson Group (ASX: JHG) share price on Thursday after the fund manager's quarterly update underwhelmed. Janus Henderson reported first quarter operating income of US$124.6 million. This was down 21% from the fourth quarter and 35.3% over the prior corresponding period.

Qantas acquisition

The Qantas Airways Limited (ASX: QAN) share price is falling today after the airline operator announced an agreement to acquire Alliance Aviation Services Ltd (ASX: AQZ). The company has offered one Qantas share per Alliance share. This represents a 35% premium to the $3.51 Alliance share price at yesterday's close and values the fly-in, fly-out operator at an enterprise value of $919.2 million.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Thursday has been the Imugene Limited (ASX: IMU) share price with a 7% gain. The biotech's shares are rebounding after crashing to a 52-week low this week. Going the other way, the Janus Henderson share price is the worst performer with a 15% decline. This follows the fund manager's aforementioned quarterly update.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was one for the record books this Wednesday.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
ASX Share Market News

Record breaker! The ASX 200 just hit a fresh all-time high

Investors just sent the ASX 200 into uncharted territory.

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
ASX Share Market News

Why is everyone talking about Domino's, Light & Wonder and BHP shares on Wednesday?

BHP, Light & Wonder, and Domino’s shares are turning heads today. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
ASX Share Market News

Earnings preview: can Cochlear shares rebound?

A decade low share price meets a make-or-break result.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »